Search - tctmd.com

Displaying 1 - 20 of 98

Sort: Relevancy | Date

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Daily News

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Michael O'Riordan

March 31, 2023

News Daily News

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Yael L. Maxwell

February 15, 2023

News Daily News

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Michael O'Riordan

January 17, 2023

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Todd Neale

December 02, 2022

News Daily News

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

Michael O'Riordan

November 22, 2022

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Daily News

New Biomarker-Based Risk Score Performs Well in ACS

Michael O'Riordan

October 25, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

Advertisement

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Top Coronary Artery Disease News in 2024

DES Best for In-Stent Restenosis, but DCBs Also Viable

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI

Surgical Turndown Patients Need Better Risk Estimation Tools: OPTIMUM

Medical Devices Cleared on Faulty Predicates More Likely to be Recalled

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

FFR Pullback Measure Linked to Likelihood of Angina Relief After PCI

Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Many STEMI Patients Not Treated Within National Time Goals

New Biomarker-Based Risk Score Performs Well in ACS

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Good News and Bad for High-Intensity Statin Use in ASCVD

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content